Test Code 4282SP
Test Name Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma
Test has pending updates: 02/07/2022
Test Includes
1 | 5-fluoro-MMB-PINACA | 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.05 | Synthetic Cannabinoid | |
2 | CUMYL-THPINACA | N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
3 | MDMB-FUBICA | methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
4 | MMB-FUBINACA | FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
5 | 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA | 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
6 | MMB-FUBICA | methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
7 | MDMB-FUBINACA / EMB-FUBINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
8 | 5-fluoro-EDMB-PINACA | ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
9 | NA-FUBIM | (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
10 | 5-fluoro-QU-PINAC | 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
11 | MMB-CHMICA | methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
12 | NA-FUBIC | 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
13 | MDMB-CHMICA | methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
14 | 5-fluoro-NA-PIC | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
15 | MMB-CHMINACA | MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
16 | MDMB-CHMINAC | MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
17 | ADAMANTYL-FUBINACA | FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
18 | MDMB-CHMCZCA | methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
19 | AMB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
20 | ADMB-FUBINACA | ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
21 | ADMB-FUBICA | ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
22 | 4-cyano-CUMYL-BINACA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
23 | AMB-CHMINACA | AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
24 | 4-fluoro-MDMB-BINACA | 4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
25 | 5-fluoro-MDMB-PICA | methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
26 | ADMB-CHMINACA | ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid |
Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Additional Collection Instructions
Rejection criteria pertain to clinical sample submissions only.
1 | 5-fluoro-MMB-PINACA | 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.05 | Synthetic Cannabinoid | |
2 | CUMYL-THPINACA | N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
3 | MDMB-FUBICA | methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
4 | MMB-FUBINACA | FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
5 | 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA | 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
6 | MMB-FUBICA | methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
7 | MDMB-FUBINACA / EMB-FUBINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
8 | 5-fluoro-EDMB-PINACA | ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
9 | NA-FUBIM | (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
10 | 5-fluoro-QU-PINAC | 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
11 | MMB-CHMICA | methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
12 | NA-FUBIC | 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
13 | MDMB-CHMICA | methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
14 | 5-fluoro-NA-PIC | naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
15 | MMB-CHMINACA | MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
16 | MDMB-CHMINAC | MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
17 | ADAMANTYL-FUBINACA | FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
18 | MDMB-CHMCZCA | methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
19 | AMB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
20 | ADMB-FUBINACA | ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
21 | ADMB-FUBICA | ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
22 | 4-cyano-CUMYL-BINACA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
23 | AMB-CHMINACA | AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 1 | Synthetic Cannabinoid | |
24 | 4-fluoro-MDMB-BINACA | 4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
25 | 5-fluoro-MDMB-PICA | methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid | |
26 | ADMB-CHMINACA | ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.1 | Synthetic Cannabinoid |
Interface Mapping
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
LOINC® Information
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.
*The information contained in this document represents database configurations, as they will appear on the effective date listed above.